Dutch Cancer Foundation (KWF) grant for Dömling
Prof. Alex Dömling, Drug Design group of GRIP, together with co-workers of the UMCG (Profs. H. Nijmans and P. Elsinga) recently was awarded a grant of approx. €840.000 by the Dutch Cancer Foundation (KWF) research and implementation programme. The project is titled: Non-invasive whole-body imaging of immune checkpoints using radiolabeled small molecules as predictive biomarker for response to therapy.
In the project, small molecules will be developed for use as PET tracers and provide proof-of-concept for their use as a predictive biomarker. The multidisciplinary team of clinicians, chemists, nuclear medicine specialists and preclinical research staff involved in this project makes us uniquely suited to develop an imaging product with near-future clinical applications.
Last modified: | 08 June 2017 1.25 p.m. |
More news
-
10 September 2025
Funding for Feringa and Minnaard from National Growth Fund project Big Chemistry
Two UG research projects have received funding from the National Growth Fund project Big Chemistry via NWO.
-
09 September 2025
The carbon cycle as Earth’s thermostat
Earth's natural carbon cycle becomes unbalanced if we, humans, continue to release extra carbon dioxide (CO2) into the atmosphere. In this overview article about the carbon cycle, you can find out how Earth generally keeps itself in balance and how...
-
09 September 2025
Carbon dioxide’s fingerprint
In the year 2000, Harro Meijer, Professor of Isotope Physics at the University of Groningen, set up the Lutjewad Measurement Station near Hornhuizen. There, researchers from Groningen are mapping where CO2 in the atmosphere originates and where it...